Zdrowie i gospodarka · 01/07/2014

FDA Reopens Comment Period for Over-the-Counter Drug Monograph System

The Food and Drug Administration (FDA) is reopening the comment period for the public hearing on the Over-the-Counter (OTC) Monograph Process, allowing for updates and new information to be submitted regarding the review of nonprescription drugs marketed under the OTC Drug Review.